Home > Drug Search >
  • company_query: Bharat Biotech
  •   > 
Drug Filter
Category:
chemistry (16) biology (41)
Status:
Approved (15) NDA Filing (1) BLA Filing (2) Phase Ⅲ (10) Phase Ⅱ (18) Phase Ⅰ (11)
Clinical Stage:
Pending (8) Active (27) Discontinued (7)
Bio-Type:
Gene therapy (3) Vaccine (9) Blood extraction (5) Animal extract (1) Recombinant cytokines (5) Recombinant hormone (1) Other recombinant protein (1) Whole antibody (11) Fusion protein (2)
Indication:
Meningitis (1) Acute bacterial exacerbation of chronic obstructive pulmonary disease (1) Acute coronary syndrome (ACS) (1) Amyotrophic lateral sclerosis (ALS) (1) Anemia (3) Breast cancer (2) Chronic obstructive pulmonary disease (COPD) (1) Community-acquired pneumonia (CAP) (1) Deep vein thrombosis (DVT) (1) Dry eye disease (1) Epilepsy/Seizures (1) wound (1) Eye disorders (1) Wet age-related macular degeneration (1) Cytomegalovirus infections (1) HBV infection (7) HCV infection (2) Hepatocellular carcinoma (HCC) (2) HIV infection (1) Huntington's disease (1) Hypertension (1) Inflammatory bowel disease (1) Lymphoma (1) Melanoma (1) Multiple sclerosis (MS) (2) Myocardial infarction (MI) (3) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (3) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin’s lymphoma (NHL) (2) Osteoporosis (1) Ovarian cancer (1) Pancreatic cancer (1) Pneumonia (2) Viral infections (1) Diphtheria (2) Haemophilus infection (2) Pertussis (2) Prostate cancer (1) Tetanus (2) Psoriasis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (4) Chronic granulomatous disease (1) Solid tumours (4) Rotavirus infection (1) Leber congenital amaurosis (1) Type 2 diabetes (2) Nasopharyngeal cancer (1) Colorectal cancer (2) Diabetic foot ulcers (1) Pain (1) Stroke (1) Unstable angina (1) Otitis Media (1) Type 1 diabetes (1) Neutropenia (2) Autoimmune diseases (1) Metastatic cancer (1) Bleeding (1) Systemic sclerosis (1) Burns (1) Mesothelioma (1) Corneal disorders (1) Bacterial infection (1) Immunodeficiency disorders (1) hematological malignancies (1)
Country:
Aprv. Year:
2003 (1) 2012 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top